This is the classic website, which will be retired eventually. Please visit the modernized ClinicalTrials.gov instead.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Intraoperative Monitoring to Predict Postoperative Complications After Thyroidectomy (PARACAL)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03309384
Recruitment Status : Recruiting
First Posted : October 13, 2017
Last Update Posted : January 12, 2022
Sponsor:
Information provided by (Responsible Party):
Laurent BRUNAUD, Central Hospital, Nancy, France

Study Description
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
The goal of this study is to evaluate the role of intraoperative continous and intermittent neuromonitoring and intraoperative parathormone (PTH) to predict postoperative nerve morbidity and hypocalcemia.

Condition or disease
Endocrine Procedural Complications Thyroid Parathyroid; Deficiency Laryngeal Injury

Detailed Description:

Intraoperative PTH values and intraoperative continuous neuromonitoring will be collected prospectively in consecutive patients who undergo total thyroidectomy.

Postoperative parathyroid morbidity and recurrent laryngeal nerve morbidity will be evaluated within 1 week after total thyroidectomy and at 1 year postoperatively.

Other postoperative morbidity will be evaluated at 1 year postoperatively using validated classification.

Study Design
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Observational [Patient Registry]
Estimated Enrollment : 1000 participants
Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration: 1 Year
Official Title: Intraoperative Monitoring (Parathormone Values and Continuous Neuromonitoring) to Predict Postoperative Complications After Total Thyroidectomy
Study Start Date : March 20, 2016
Estimated Primary Completion Date : March 20, 2026
Estimated Study Completion Date : March 20, 2026

Resource links provided by the National Library of Medicine

MedlinePlus related topics: After Surgery

Groups and Cohorts
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information


Outcome Measures
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. intraoperative parathormone values [ Time Frame: intraoperative ]
    parathormone in pg/mL


Secondary Outcome Measures :
  1. postoperative hypocalcemia [ Time Frame: within 1 week after thyroidectomy ]
    calcium in mg/L

  2. postoperative hypoparathyroidism [ Time Frame: within 1 week after thyroidectomy ]
    parathormone in pg/mL

  3. permanent postoperative hypocalcemia [ Time Frame: at one year after thyroidectomy ]
    calcium in mg/L

  4. permanent postoperative hypoparathyroidism [ Time Frame: at one year after thyroidectomy ]
    parathormone in pg/mL

  5. laryngeal nerve palsy [ Time Frame: during thyroidectomy ]
    continuous intraoperative neuromonitoring (> 50% baseline values yes/no)

  6. laryngeal nerve palsy [ Time Frame: within 1 week after thyroidectomy ]
    laryngoscopy (normal / palsy)

  7. laryngeal nerve palsy [ Time Frame: at one year after thyroidectomy ]
    laryngoscopy (normal / palsy)

  8. Postoperative complications other than outcomes from 1 to 8 [ Time Frame: at one year after thyroidectomy ]
    Postoperative morbidity classification (using a Clavien-Dindo classification) postoperatively


Eligibility Criteria
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
All patients scheduled for total thyroidectomy in university of Nancy (University Hospital)
Criteria

Inclusion Criteria:

  • patients scheduled for total thyroidectomy in university of Nancy (University Hospital)

Exclusion Criteria:

  • refusal to participate
Contacts and Locations
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03309384


Contacts
Layout table for location contacts
Contact: Brunaud l.brunaud@chru-nancy.fr
Contact: Jacquel s.jacquel@chru-nancy.fr

Locations
Layout table for location information
France
CHU Nancy Recruiting
Vandœuvre-lès-Nancy, France, 54511
Contact: laurent Brunaud       l.brunaud@chru-nancy.fr   
Sponsors and Collaborators
Central Hospital, Nancy, France
Investigators
Layout table for investigator information
Principal Investigator: Brunaud CHU Nancy
More Information
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Additional Information:

Layout table for additonal information
Responsible Party: Laurent BRUNAUD, Professor of Surgery, MD, PhD, Central Hospital, Nancy, France
ClinicalTrials.gov Identifier: NCT03309384    
Other Study ID Numbers: PARACAL
R2016-25 ( Registry Identifier: CNIL )
First Posted: October 13, 2017    Key Record Dates
Last Update Posted: January 12, 2022
Last Verified: January 2022

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Hypoparathyroidism
Postoperative Complications
Pathologic Processes
Parathyroid Diseases
Endocrine System Diseases